DK3197431T3 - Skumdannende sammensætninger og fremgangsmåder til fremføring af et aktivt middel til en legemshulhed - Google Patents
Skumdannende sammensætninger og fremgangsmåder til fremføring af et aktivt middel til en legemshulhed Download PDFInfo
- Publication number
- DK3197431T3 DK3197431T3 DK15843723.6T DK15843723T DK3197431T3 DK 3197431 T3 DK3197431 T3 DK 3197431T3 DK 15843723 T DK15843723 T DK 15843723T DK 3197431 T3 DK3197431 T3 DK 3197431T3
- Authority
- DK
- Denmark
- Prior art keywords
- delivering
- methods
- active agent
- body cavity
- foaming compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/122—Foams; Dry foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/40—Peroxides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0043—Nose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0046—Ear
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
- A61K9/124—Aerosols; Foams characterised by the propellant
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Dispersion Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Reproductive Health (AREA)
- Urology & Nephrology (AREA)
- Inorganic Chemistry (AREA)
- Otolaryngology (AREA)
- Gynecology & Obstetrics (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462055001P | 2014-09-25 | 2014-09-25 | |
| PCT/SE2015/051011 WO2016048230A1 (en) | 2014-09-25 | 2015-09-25 | Foam-forming compositions and methods for delivering an active agent to a body cavity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3197431T3 true DK3197431T3 (da) | 2023-06-06 |
Family
ID=55581573
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK15843723.6T DK3197431T3 (da) | 2014-09-25 | 2015-09-25 | Skumdannende sammensætninger og fremgangsmåder til fremføring af et aktivt middel til en legemshulhed |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US9895311B2 (https=) |
| EP (2) | EP3197431B1 (https=) |
| JP (1) | JP6659674B2 (https=) |
| KR (1) | KR102569954B1 (https=) |
| CN (1) | CN106687109B (https=) |
| AU (1) | AU2015322112B2 (https=) |
| BR (1) | BR112017006154B1 (https=) |
| CA (1) | CA2959717C (https=) |
| DK (1) | DK3197431T3 (https=) |
| ES (1) | ES2946510T3 (https=) |
| FI (1) | FI3197431T3 (https=) |
| HU (1) | HUE062224T2 (https=) |
| PL (1) | PL3197431T3 (https=) |
| PT (1) | PT3197431T (https=) |
| RU (1) | RU2710019C2 (https=) |
| WO (1) | WO2016048230A1 (https=) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
| CA3030408A1 (en) * | 2016-07-11 | 2018-01-18 | Hennepin Life Sciences, Llc | Compositions for sexually transmitted diseases |
| CA3063208A1 (en) * | 2017-05-23 | 2018-11-29 | Pharmiva Ab | Foam-forming compositions for delivering an active to a body cavity |
| CA3204971A1 (en) | 2021-01-27 | 2022-08-04 | Ake Lindal | Composition for use in degradation of biofilm or prevention of biofilm formation |
| JP2024522372A (ja) * | 2021-06-11 | 2024-06-18 | アンク、ライフ、サイエンシズ、リミテッド | 有効薬剤の組合せの局所送達のための安定性が向上した脂質結晶性組成物 |
Family Cites Families (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684479A (en) | 1985-08-14 | 1987-08-04 | Arrigo Joseph S D | Surfactant mixtures, stable gas-in-liquid emulsions, and methods for the production of such emulsions from said mixtures |
| SE454397B (sv) * | 1985-12-20 | 1988-05-02 | Biogram Ab | Stabiliserad vattenbaserad antimikrobiell veteperoxidkomposition, forfarande for framstellning derav samt anvendning derav som antimikrobiell spendoppningskomposition for mjolkproducerande djur |
| JPH06279228A (ja) | 1993-03-30 | 1994-10-04 | Kao Corp | 発泡性組成物 |
| US5576016A (en) * | 1993-05-18 | 1996-11-19 | Pharmos Corporation | Solid fat nanoemulsions as drug delivery vehicles |
| JPH07197083A (ja) | 1993-12-28 | 1995-08-01 | Kao Corp | 洗浄剤組成物 |
| US5741525A (en) | 1995-10-24 | 1998-04-21 | Marshall University Research Corporation | Vaginal pharmaceutical hydrogen peroxide composition |
| US5778886A (en) * | 1996-02-27 | 1998-07-14 | Shihata; Alfred | Vaginal compositions combining a spermicidal agent and a peroxygen compound |
| US6156294A (en) | 1999-11-28 | 2000-12-05 | Scientific Development And Research, Inc. | Composition and method for treatment of otitis media |
| US20020031556A1 (en) * | 2000-07-21 | 2002-03-14 | Lindahl Ake R. | Stabilized hydrogen peroxide composition and method of making a stabilized hydrogen peroxide composition |
| US7709026B2 (en) | 2001-10-29 | 2010-05-04 | Columbia Laboratories, Inc. | Low concentration of peroxide for treating or preventing vaginal infections |
| US20070292355A1 (en) * | 2002-10-25 | 2007-12-20 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
| EA014372B1 (ru) | 2003-01-24 | 2010-10-29 | Стифел Рисерч Оустрэйлиа Пти Лтд. | Пена на основе фосфата клиндамицина |
| US8193244B1 (en) | 2008-05-29 | 2012-06-05 | Nevada Naturals, Inc. | Antimicrobial agents |
| US20040197270A1 (en) * | 2003-04-01 | 2004-10-07 | Mundschenk David D. | Topical formulations and delivery systems |
| EP1663148A2 (en) * | 2003-08-25 | 2006-06-07 | Foamix Ltd. | Penetrating pharmaceutical foam |
| US20050058673A1 (en) | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
| EP1768648A1 (en) | 2004-04-28 | 2007-04-04 | Foamix Ltd. | Body cavity foams |
| EP1858506A2 (en) | 2005-03-10 | 2007-11-28 | 3M Innovative Properties Company | Methods of treating ear infections |
| US20070299043A1 (en) * | 2005-10-03 | 2007-12-27 | Hunter William L | Anti-scarring drug combinations and use thereof |
| US20080299520A1 (en) * | 2005-12-29 | 2008-12-04 | Ali Mahfuza B | Foamable Dental Compositions and Methods |
| WO2008075207A2 (en) | 2006-04-04 | 2008-06-26 | Foamix Ltd. | Anti-infection augmentation foamable compositions and kit and uses thereof |
| WO2008110872A2 (en) * | 2006-06-23 | 2008-09-18 | Foamix Ltd. | Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses |
| ES2482190T3 (es) * | 2007-03-30 | 2014-08-01 | Laccure Ab | Uso de oligómeros de ácido láctico en el tratamiento de infecciones ginecológicas |
| RS52337B (sr) * | 2007-06-19 | 2012-12-31 | Neubourg Skin Care Gmbh & Co. Kg | Dms kreme na bazi pene |
| US20090239954A1 (en) * | 2008-03-19 | 2009-09-24 | Collins Gary L | Phosphate buffered ophthalmic solutions displaying improved efficacy |
| US10029013B2 (en) | 2009-10-02 | 2018-07-24 | Foamix Pharmaceuticals Ltd. | Surfactant-free, water-free formable composition and breakable foams and their uses |
| US8414868B2 (en) * | 2010-02-04 | 2013-04-09 | Ultradent Products, Inc. | In situ foamable dental bleaching compositions and methods, systems and kits for bleaching teeth using such compositions |
| EP2988731B1 (en) * | 2013-04-26 | 2021-02-17 | Bioglan Ab | Composition for use in reducing scab formation and promoting healing |
| US9895311B2 (en) * | 2014-09-25 | 2018-02-20 | Pharmiva Ab | Foam-forming compositions and methods for delivering an active to a body cavity |
-
2015
- 2015-09-24 US US14/864,083 patent/US9895311B2/en not_active Expired - Fee Related
- 2015-09-25 HU HUE15843723A patent/HUE062224T2/hu unknown
- 2015-09-25 JP JP2017516659A patent/JP6659674B2/ja not_active Expired - Fee Related
- 2015-09-25 CN CN201580051590.3A patent/CN106687109B/zh not_active Expired - Fee Related
- 2015-09-25 EP EP15843723.6A patent/EP3197431B1/en active Active
- 2015-09-25 DK DK15843723.6T patent/DK3197431T3/da active
- 2015-09-25 KR KR1020177010958A patent/KR102569954B1/ko active Active
- 2015-09-25 AU AU2015322112A patent/AU2015322112B2/en not_active Ceased
- 2015-09-25 CA CA2959717A patent/CA2959717C/en active Active
- 2015-09-25 PL PL15843723.6T patent/PL3197431T3/pl unknown
- 2015-09-25 EP EP23156021.0A patent/EP4218803A3/en not_active Withdrawn
- 2015-09-25 RU RU2017112055A patent/RU2710019C2/ru active
- 2015-09-25 FI FIEP15843723.6T patent/FI3197431T3/fi active
- 2015-09-25 WO PCT/SE2015/051011 patent/WO2016048230A1/en not_active Ceased
- 2015-09-25 PT PT158437236T patent/PT3197431T/pt unknown
- 2015-09-25 BR BR112017006154-6A patent/BR112017006154B1/pt not_active IP Right Cessation
- 2015-09-25 ES ES15843723T patent/ES2946510T3/es active Active
Also Published As
| Publication number | Publication date |
|---|---|
| JP2017529377A (ja) | 2017-10-05 |
| RU2017112055A (ru) | 2018-10-25 |
| BR112017006154A2 (en) | 2018-02-06 |
| EP3197431B1 (en) | 2023-03-08 |
| EP4218803A2 (en) | 2023-08-02 |
| US9895311B2 (en) | 2018-02-20 |
| PT3197431T (pt) | 2023-05-10 |
| RU2710019C2 (ru) | 2019-12-24 |
| US20160089333A1 (en) | 2016-03-31 |
| EP3197431A4 (en) | 2018-04-04 |
| AU2015322112A1 (en) | 2017-03-30 |
| HUE062224T2 (hu) | 2023-10-28 |
| WO2016048230A1 (en) | 2016-03-31 |
| ES2946510T3 (es) | 2023-07-20 |
| CN106687109B (zh) | 2020-10-23 |
| EP3197431A1 (en) | 2017-08-02 |
| CA2959717A1 (en) | 2016-03-31 |
| KR20170059000A (ko) | 2017-05-29 |
| PL3197431T3 (pl) | 2023-06-19 |
| KR102569954B1 (ko) | 2023-08-22 |
| FI3197431T3 (fi) | 2023-05-11 |
| JP6659674B2 (ja) | 2020-03-04 |
| CN106687109A (zh) | 2017-05-17 |
| RU2017112055A3 (https=) | 2019-03-25 |
| BR112017006154B1 (pt) | 2024-01-23 |
| CA2959717C (en) | 2022-10-18 |
| AU2015322112B2 (en) | 2020-10-22 |
| EP4218803A3 (en) | 2023-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3797742T3 (da) | Indretning til suprakoroidal indgivelse af terapeutisk middel | |
| IL250685A0 (en) | Medicinal substance induces cytotoxicity | |
| IL250689B (en) | Rearrangement of multipurpose stem cells | |
| IL251576A0 (en) | Methods and compositions for creating or maintaining multifunctional cells | |
| DK3177640T3 (da) | Pd-1-midler med høj affinitet og anvendelsesfremgangsmåder | |
| DK3234107T3 (da) | B-celler til in vivo-levering af terapeutiske midler | |
| DK3240785T3 (da) | Småmolekylede hæmmere af laktasedehydrogenase og fremgangsmåder til brug deraf | |
| DK3511019T3 (da) | Terapeutiske nanopartikler omfattende et terapeutisk middel og fremgangsmåder til fremstilling og anvendelse deraf | |
| DK3223829T3 (da) | Behandling af sygdomme associeret med hepatisk stellat-celleaktivering under anvendelse af ammoniak-sænkende terapier | |
| SG11201610699XA (en) | Manufacture and cryopreservation of fucosylated cells for therapeutic use | |
| DK2968440T3 (da) | Cytotoksiske og antimitotiske forbindelser samt fremgangsmåder til anvendelse heraf | |
| DK3233111T3 (da) | Farmaceutisk sammensætning, der omfatter plasminogen, og anvendelser deraf | |
| HRP20190127T1 (hr) | Derivati pirolidinona kao inhibitori metap-2 | |
| PL3194421T3 (pl) | Związki cytotoksyczne i przeciwmitotyczne oraz sposoby ich wykorzystania | |
| DK3104961T3 (da) | Reaktionsdygtig sammensætning på basis af natriumbicarbonat og fremgangsmåde til fremstilling heraf | |
| HUE060732T2 (hu) | Terápiás szer fibrózisra | |
| DK2974728T3 (da) | Terapeutisk middel til meibomsk dysfunktion | |
| DK3104960T3 (da) | Reaktiv sammensætning baseret på natriumbicarbonat og fremgangsmåde til fremstilling deraf | |
| DK3197431T3 (da) | Skumdannende sammensætninger og fremgangsmåder til fremføring af et aktivt middel til en legemshulhed | |
| GB201706571D0 (en) | Active waterway stabilizer | |
| DK3240529T3 (da) | Stabile farmaceutiske sammensætninger omfattende micafungin | |
| HRP20181542T1 (hr) | Postupak za ekspandiranje zrelih matičnih stanica iz pune krvi | |
| LT3270923T (lt) | Terapinis agentas priekinės skilties disfunkcijai | |
| SMT202000024T1 (it) | Derivati di bis (solfonammide) e loro uso come inibitori di mpges | |
| TH1601001543A (th) | สารรวมของสารประกอบออกฤทธิ์ |